Dengvaxia and its manufacturer, Sanofi Pasteur, as well as officials of the Aquino administration have been the subject of congressional investigations. This was after Sanofi announced an update in late 2017, acknowledging that the vaccine exposed recipients to more severe dengue if they got Dengvaxia without having developed the infection before. – Rappler.com